Efficacy of statin therapy in chronic systolic cardiac insufficiency: A meta-analysis

European Journal of Internal Medicine

Volumn 22, Issue 5, 2011, Pages 478-484

  Zhang, Shuning ^a   Zhang, Lei ^a   Sun, Aijun ^a   Jiang, Hong ^a   Qian, Juying ^a   Ge, Junbo ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Chronic heart failure; Meta analysis; Outcomes; Statin

Indexed keywords

ATORVASTATIN; NEUROHORMONE; PLACEBO; ROSUVASTATIN; SIMVASTATIN;

AGE; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; COCHRANE LIBRARY; DISEASE MARKER; DRUG EFFICACY; EMBASE; EQUIPMENT; FOLLOW UP; FUNCTION TEST; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE SIZE; HEART RATE VARIABILITY; HOSPITAL READMISSION; HUMAN; MEDLINE; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; QT DISPERSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SUDDEN DEATH; SYSTEMATIC REVIEW; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

HEART FAILURE, SYSTOLIC; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 80052971702     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2011.06.003     Document Type: Article

References (31)

1. F.M. Sacks, M.A. Pfeffer, L.A. Moye, J.L. Rouleau, J.D. Rutherford, and T.G. Cole The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators N Engl J Med 335 1996 1001 1009 (Pubitemid 26338729)
2. M.K. Jain, and P.M. Ridker Anti-inflammatory effects of statins: clinical evidence and basic mechanisms Nat Rev Drug Discov 4 2005 977 987
3. P. Dilaveris, G. Giannopoulos, M. Riga, A. Synetos, and C. Stefanadis Beneficial effects of statins on endothelial dysfunction and vascular stiffness Curr Vasc Pharmacol 5 2007 227 237
4. H. Krum, and J.J. McMurray Statins and chronic heart failure: do we need a large-scale outcome trial? J Am Coll Cardiol 39 2002 1567 1573 (Pubitemid 34494279)
5. J.G. Ray, Y. Gong, and K.T.J.V. Sykora Statin use and survival outcomes in elderly patients with heart failure Arch Intern Med 165 2005 62 67 (Pubitemid 40096083)
6. T.B. Horwich, W.R. MacLellan, and G.C. Fonarow Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure J Am Coll Cardiol 43 2004 642 648 (Pubitemid 38229538)
7. D. Mozaffarian, R. Nye, and W.C. Levy Statin therapy is associated with lower mortality among patients with severe heart failure Am J Cardiol 93 2004 1124 1129 (Pubitemid 38521041)
8. M. Roik, M.H. Starczewska, Z. Huczek, J. Kochanowski, and G. Opolski Statin therapy and mortality among patients hospitalized with heart failure and preserved left ventricular function - a preliminary report Acta Cardiol 63 2008 683 692
9. J. Kjekshus, E. Apetrei, V. Barrios, M. Böhm, J.G. Cleland, and J.H. Cornel Rosuvastatin in older patients with systolic heart failure N Engl J Med 357 2007 2248 2261 (Pubitemid 350190755)
10. L. Tavazzi, A.P. Maggioni, R. Marchioli, S. Barlera, M.G. Franzosi, and R. Latini Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial Lancet 372 2008 1231 1239
11. A.R. Jadad, R.A. Moore, D. Carroll, C. Jenkinson, D.J. Reynolds, and D.J. Gavaghan Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trial 17 1996 1 12 (Pubitemid 26120810)
12. J.P. Ioannidis, N.A. Patsopoulos, and E. Evangelou Uncertainty in heterogeneity estimates in meta-analyses BMJ 335 2007 914 916 (Pubitemid 350076978)
13. J.P. Ioannidis, and T.A. Trikalinos The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey CMAJ 176 2007 1091 1096 (Pubitemid 46649731)
14. A. Bielecka-Dabrowa, J.H. Goch, and D.P. Mikhailidis The influence of atorvastatin on parameters of inflammation and function of the left ventricle in patients with dilated cardiomyopathy Med Sci Monit 15 2009 MS12 MS23
15. A. Hamaad, M. Sosin, G.Y. Lip, and R.J. MacFadyen Short-term adjuvant atorvastatin improves frequency domain indices of heart rate variability in stable systolic heart failure Cardiovasc Drugs Ther 19 2005 183 187 (Pubitemid 41253210)
16. S. Sola, M.Q. Mir, S. Lerakis, N. Tandon, and B.V. Khan Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure J Am Coll Cardiol 47 2006 332 337 (Pubitemid 43063250)
17. B. Vrtovec, R. Okrajsek, A. Golicnik, M. Ferjan, V. Starc, and T.T. Schlegel Atorvastatin therapy may reduce the incidence of sudden cardiac death in patients with advanced chronic heart failure J Card Fail 14 2008 140 144 (Pubitemid 351312881)
18. R. Wojnicz, K. Wilczek, E. Nowalany-Kozielska, B. Szyguła- Jurkiewicz, J. Nowak, and L. Poloński Usefulness of atorvastatin in patients with heart failure due to inflammatory dilated cardiomyopathy and elevated cholesterol levels Am J Cardiol 97 2006 899 904
19. T. Yamada, K. Node, T. Mine, T. Morita, H. Kioka, and Y. Tsukamoto Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study Am Heart J 153 2007 e1 e8
20. R.Q. Xie, W. Cui, F. Liu, C. Yang, W.N. Pei, and J.C. Lu Statin therapy shortens QTc, QTcd, and improves cardiac function in patients with chronic heart failure Int J Cardiol 140 2010 255 257
21. D. Mozaffarian, E. Minami, R.A. Letterer, R.L. Lawler, G.B. McDonald, and W.C. Levy The effects of atorvastatin (10 mg) on systemic inflammation in heart failure Am J Cardiol 96 2005 1699 1704 (Pubitemid 41790394)
22. Y.J. Hong, M.H. Jeong, D.W. Hyun, S.H. Hur, K.B. Kim, and W. Kim Prognostic significance of simvastatin therapy in patients with ischemic heart failure who underwent percutaneous coronary intervention for acute myocardial infarction Am J Cardiol 95 2005 619 622 (Pubitemid 40255252)
23. K. Node, M. Fujita, M. Kitakaze, M. Hori, and J.K. Liao Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy Circulation 108 2003 839 843 (Pubitemid 37022126)
24. H. Krum, E. Ashton, C. Reid, V. Kalff, J. Rogers, and J. Amarena Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure J Card Fail 13 2007 1 7 (Pubitemid 46330836)
25. J.G. Cleland, J.J. McMurray, J. Kjekshus, J.H. Cornel, P. Dunselman, and C. Fonseca Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure) J Am Coll Cardiol 54 2009 1850 1859
26. V. Barrios, and C. Escobar Rosuvastatin and cardiovascular continuum when time is important J Am Coll Cardiol 55 2010 1645 1646
27. K. Nezasa, K. Higaki, T. Matsumura, K. Inazawa, H. Hasegawa, and M. Nakano Liver-specific distribution of rosuvastatin in rats: comparison with pravastatin and simvastatin Drug Metab Dispos 30 2002 1158 1163 (Pubitemid 35265820)
28. J.S. Ford, and J.A. Tayek Lipophilicity and cardiovascular outcome in patients with CHF Am Heart J 156 2008 e7
29. M. Schachter Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update Fundam Clin Pharmacol 19 2005 117 125 (Pubitemid 40204354)
30. M.J. Tikkanen, I. Holme, N.B. Cater, M. Szarek, O. Faergeman, and J.J. Kastelein Comparison of efficacy and safety of atorvastatin (80 mg) to simvastatin (20 to 40 mg) in patients aged < 65 versus > or = 65 years with coronary heart disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] study) Am J Cardiol 103 2009 577 582
31. W.H. Tang, and G.S. Francis Statin treatment for patients with heart failure Nat Rev Cardiol 7 2010 249 255